NCT06759636 2025-01-06
FRIENDS-01：A Multicenter Open-label Randomized Controlled Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Not yet recruiting